Artificial Intelligence in Drug Development. Dieser Artikel ist nicht verfügbar.Artificial Intelligence in Drug Development

This book explores the transformative role of Artificial Intelligence (AI) in the field of drug development. It examines how AI accelerates drug discovery by predicting molecular interactions, identifying promising compounds, and reducing time and cost. The book delves into AI-powered mechanisms for analysing drug actions and understanding biological pathways, providing deeper insight into therapeutic effects. Moreover, it addresses AI’s critical role in safety assessment, enabling early detection of potential adverse effects and enhancing decision-making in preclinical and clinical phases. With case studies and current research trends, the book serves as a comprehensive guide for researchers, pharmaceutical professionals, and anyone interested in the intersection of AI and biomedical innovation.

Dr. Seyed Ahmad Hosseini, a 1993 pharmacy graduate, holds MBA, DBA, and Post-DBA degrees. With nearly 30 years of experience in the pharmaceutical field, he has received multiple awards, authored two management books, and served as Deputy Director of Health Services in Qom Province.